SCHEMBL108955

SCHEMBL108955

CC1CC(N)CCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21940866 1.00 — —
SCHEMBL24150524 1.00 — —
SCHEMBL29044493 1.00 — —
SCHEMBL29044517 1.00 — —
SCHEMBL21940867 1.00 — —
Hydrochloric Acid SCHEMBL27555310 0.98 GNAI3 (0.35) —
Hydrochloric Acid SCHEMBL1992978 0.98 GNAI3 (0.35) —
Hydrochloric Acid SCHEMBL5324439 0.98 GNAI3 (0.35) —
Acetic Acid SCHEMBL28653592 0.88 SMYD3 (0.33) —
Formic Acid SCHEMBL28931254 0.88 SMYD3 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 323 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036239-A Resin asphalt concrete for steel bridge surface ERS pavement and preparation method thereof 宁波天意钢桥面铺装工程有限公司 2026-05-15 — — CN claimed
CN-119874374-A Silicon carbide composite ceramic and preparation method thereof 常州赛璞睿生科技有限公司 2025-04-25 — — CN claimed
EP-4416146-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-C] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF Lomond Therapeutics, Inc. (US) 2024-08-21 — — EP claimed
CN-113614069-B Process for preparing (3R, 4R) -1-benzyl-N, 4-dimethylpiperidin-3-amine or a salt thereof and process for preparing tofacitinib using the same 柳韩洋行 2024-05-28 — — CN claimed
CN-114807071-B Enzymatic preparation method of tofacitinib key intermediate 中国科学院天津工业生物技术研究所 2023-10-20 — — CN claimed
CN-113930404-B Method for synthesizing chiral tofacitinib citrate intermediate by enzymatic method 浙江乐普药业股份有限公司 2023-10-13 — — CN claimed
WO-2023064133-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF LOMOND THERAPEUTICS, INC. (US) 2023-04-20 — — WO claimed
CN-115808472-A Method for analyzing and detecting impurity BMPA-3 in R-BMPA 江苏万邦生化医药集团有限责任公司 2023-03-17 — — CN claimed
CN-114807071-A Enzymatic preparation method of tofacitinib key intermediate 中国科学院天津工业生物技术研究所 2022-07-29 — — CN claimed
CN-114685515-A Preparation method of tofacitinib 上海蓝乐鸟实业有限公司 2022-07-01 — — CN claimed
CN-111202736-A Compositions containing a mixture of pyrrolopyrimidine derivatives and uses thereof 黄泳华 2020-05-29 — — CN claimed
CN-110668995-A Tofacitinib citrate intermediate and preparation method of tofacitinib citrate 江苏海悦康医药科技有限公司 2020-01-10 — — CN claimed
EP-3423457-A1 PROCESS FOR THE PREPARATION OF AN ANTIBODY-RIFAMYCIN CONJUGATE H. Hoffnabb-La Roche Ag (CH) 2019-01-09 — — EP claimed
EP-2322498-B1 PROCESSES FOR REMOVING DIBENZOFULVENE AJINOMOTO KK (JP) 2014-04-16 — — EP claimed
US-20110269758-A1 NAPHTHYRIDINONES AS PROTEIN KINASE INHIBITORS MERCK PATENT GMBH (DE) 2011-11-03 — — US claimed
JP-2011526912-A — — 2011-10-20 — — JP claimed
EP-2320737-A1 PYRAZOLOÝ1,5-A¨PYRIDINES AS MARK INHIBITORS Merck & Co., Inc. (US) 2011-05-18 — — EP claimed
EP-2291376-A2 NAPHTHYRIDININONES AS AURORA KINASE INHIBITORS Merck Patent GmbH (DE) 2011-03-09 — — EP claimed
WO-2010002779-A2 NAPHTHYRIDININONES AS AURORA KINASE INHIBITORS MERCK SERONO S.A. (CH) 2010-01-07 — — WO claimed
US-4913816-A AMINE CROSSLINKED MULTILAYER POLYMER IONICS INCORPORATED (US) 1990-04-03 — — US claimed
Send feedback